Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model
Kate Guilfoyle(National Institute for Biological Standards and Control), Anders Fomsgaard(Statens Serum Institut), Heather James(National Institute for Biological Standards and Control), Othmar G. Engelhardt(National Institute for Biological Standards and Control), Jeanette Linnea Tingstedt(Statens Serum Institut), Charlotta Polacek(Statens Serum Institut), Ria Lassaunière(Statens Serum Institut), Diane Major(National Institute for Biological Standards and Control), Sarah Skeldon(National Institute for Biological Standards and Control)
Cited by 16
Related Papers
Animal models for COVID-19
|Nature|2020|877
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
|The Lancet Infectious Diseases|2022|218
Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households
|medRxiv|2022|208
Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020
|Eurosurveillance|2021|165
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
|The Lancet Infectious Diseases|2021|157